Will receive HH-009 injection 20 mg/kg, Q3W
HH009-201
Phase 2 small_molecule active
Quick answer
Will receive HH-009 injection 20 mg/kg, Q3W for Advanced or Unresectable Hepatocellular Carcinoma (HCC) is a Phase 2 program (small_molecule) at Huahui Health with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Huahui Health
- Indication
- Advanced or Unresectable Hepatocellular Carcinoma (HCC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active